Statistics
Publications
54
Citations
13.8K
H-Index
43
Active since
2003
Yangbing Zhao is an author at University of Pennsylvania specializing in immunology, life sciences, and cancer immunotherapy.
Publications per year
2003–2023
54
54
CRISPR-engineered T cells in patients with refractory cancer
Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis et al. · Science · 2020 · 1.4K citations · Full text
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons et al. · Nature · 2018 · 861 citations · Full text
1–5 of 54